163 related articles for article (PubMed ID: 35213723)
1. Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
Badodi S; Pomella N; Lim YM; Brandner S; Morrison G; Pollard SM; Zhang X; Zabet NR; Marino S
Neuro Oncol; 2022 Aug; 24(8):1273-1285. PubMed ID: 35213723
[TBL] [Abstract][Full Text] [Related]
2. Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma.
Badodi S; Dubuc A; Zhang X; Rosser G; Da Cunha Jaeger M; Kameda-Smith MM; Morrissy AS; Guilhamon P; Suetterlin P; Li XN; Guglielmi L; Merve A; Farooq H; Lupien M; Singh SK; Basson MA; Taylor MD; Marino S
Cell Rep; 2017 Dec; 21(10):2772-2784. PubMed ID: 29212025
[TBL] [Abstract][Full Text] [Related]
3. Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion.
Merve A; Dubuc AM; Zhang X; Remke M; Baxter PA; Li XN; Taylor MD; Marino S
Acta Neuropathol Commun; 2014 Jan; 2():10. PubMed ID: 24460684
[TBL] [Abstract][Full Text] [Related]
4. HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.
da Cunha Jaeger M; Ghisleni EC; Cardoso PS; Siniglaglia M; Falcon T; Brunetto AT; Brunetto AL; de Farias CB; Taylor MD; Nör C; Ramaswamy V; Roesler R
J Mol Neurosci; 2020 Jun; 70(6):981-992. PubMed ID: 32056089
[TBL] [Abstract][Full Text] [Related]
5. Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation.
Badodi S; Pomella N; Zhang X; Rosser G; Whittingham J; Niklison-Chirou MV; Lim YM; Brandner S; Morrison G; Pollard SM; Bennett CD; Clifford SC; Peet A; Basson MA; Marino S
Nat Commun; 2021 Apr; 12(1):2148. PubMed ID: 33846320
[TBL] [Abstract][Full Text] [Related]
6. BMI1 is a therapeutic target in recurrent medulloblastoma.
Bakhshinyan D; Venugopal C; Adile AA; Garg N; Manoranjan B; Hallett R; Wang X; Mahendram S; Vora P; Vijayakumar T; Subapanditha M; Singh M; Kameda-Smith MM; Qazi M; McFarlane N; Mann A; Ajani OA; Yarascavitch B; Ramaswamy V; Farooq H; Morrissy S; Cao L; Sydorenko N; Baiazitov R; Du W; Sheedy J; Weetall M; Moon YC; Lee CS; Kwiecien JM; Delaney KH; Doble B; Cho YJ; Mitra S; Kaplan D; Taylor MD; Davis TW; Singh SK
Oncogene; 2019 Mar; 38(10):1702-1716. PubMed ID: 30348991
[TBL] [Abstract][Full Text] [Related]
7. Bmi1 overexpression in the cerebellar granule cell lineage of mice affects cell proliferation and survival without initiating medulloblastoma formation.
Behesti H; Bhagat H; Dubuc AM; Taylor MD; Marino S
Dis Model Mech; 2013 Jan; 6(1):49-63. PubMed ID: 23065639
[TBL] [Abstract][Full Text] [Related]
8. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
9. Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells.
Wang X; Venugopal C; Manoranjan B; McFarlane N; O'Farrell E; Nolte S; Gunnarsson T; Hollenberg R; Kwiecien J; Northcott P; Taylor MD; Hawkins C; Singh SK
Oncogene; 2012 Jan; 31(2):187-99. PubMed ID: 21685941
[TBL] [Abstract][Full Text] [Related]
10. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.
Leung C; Lingbeek M; Shakhova O; Liu J; Tanger E; Saremaslani P; Van Lohuizen M; Marino S
Nature; 2004 Mar; 428(6980):337-41. PubMed ID: 15029199
[TBL] [Abstract][Full Text] [Related]
11. Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.
Michael LE; Westerman BA; Ermilov AN; Wang A; Ferris J; Liu J; Blom M; Ellison DW; van Lohuizen M; Dlugosz AA
Neoplasia; 2008 Dec; 10(12):1343-9, 5p following 1349. PubMed ID: 19048113
[TBL] [Abstract][Full Text] [Related]
12. Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma.
Zakrzewska M; Zakrzewski K; Grešner SM; Piaskowski S; Zalewska-Szewczyk B; Liberski PP
Childs Nerv Syst; 2011 Jan; 27(1):79-86. PubMed ID: 20717685
[TBL] [Abstract][Full Text] [Related]
13. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.
Kahn SA; Wang X; Nitta RT; Gholamin S; Theruvath J; Hutter G; Azad TD; Wadi L; Bolin S; Ramaswamy V; Esparza R; Liu KW; Edwards M; Swartling FJ; Sahoo D; Li G; Wechsler-Reya RJ; Reimand J; Cho YJ; Taylor MD; Weissman IL; Mitra SS; Cheshier SH
Nat Commun; 2018 Oct; 9(1):4121. PubMed ID: 30297829
[TBL] [Abstract][Full Text] [Related]
14. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
[TBL] [Abstract][Full Text] [Related]
15. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
[TBL] [Abstract][Full Text] [Related]
16. [PRODUCT OF THE BMI1--A KEY COMPONENT OF POLYCOMB--POSITIVELY REGULATES ADIPOCYTE DIFFERENTIATION OF MOUSE MESENCHYMAL STEM CELLS].
Petrov NS; Vereschagina NA; Sushilova EN; Kropotov AV; Miheeva NF; Popov BV
Tsitologiia; 2016; 58(2):83-90. PubMed ID: 27228653
[TBL] [Abstract][Full Text] [Related]
17. Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.
Ahmad Z; Jasnos L; Gil V; Howell L; Hallsworth A; Petrie K; Sawado T; Chesler L
PLoS One; 2015; 10(3):e0119834. PubMed ID: 25785590
[TBL] [Abstract][Full Text] [Related]
18. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
19. GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors.
Westerman BA; Blom M; Tanger E; van der Valk M; Song JY; van Santen M; Gadiot J; Cornelissen-Steijger P; Zevenhoven J; Prosser HM; Uren A; Aronica E; van Lohuizen M
PLoS One; 2012; 7(5):e35943. PubMed ID: 22574128
[TBL] [Abstract][Full Text] [Related]
20. Loss of BMI1 in mature olfactory sensory neurons leads to increased olfactory basal cell proliferation.
Choi R; Kurtenbach S; Goldstein BJ
Int Forum Allergy Rhinol; 2019 Sep; 9(9):993-999. PubMed ID: 31251849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
